Garrett Hamontree - Profile and Investment Details

Investor Profile

Garrett Hamontree is a Venture Capital, Private Equity Firm, Micro VC based in Newport Beach, California, United States with a diverse investment portfolio that includes companies such as Orasis Pharmaceuticals, RxSight, Tarsus Pharmaceuticals, Surface Pharmaceuticals, Tear Film Innovations, Re-Vana Therapeutics, Mynosys Cellular Devices, Iantech, CorneaGen, Equinox, TearClear, Bridgemark Corporation, . Over time, Garrett Hamontree has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Garrett Hamontree is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Chemical, Life Science, Information Technology (IT), Biotechnology, Market Research, Productivity Software, Clinical Trials, Reviews and Recommendations, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Garrett Hamontree, as their portfolio suggests a familiarity and interest in this area.

Understanding Garrett Hamontree’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.